-
Chapter
Repurposing Drugs for Viruses and Cancer: A Novel Drug Repositioning Strategy for COVID-19
The high infection capacity and rapid mutations in coronavirus disease 2019 (COVID-19) has been no stranger to many. The etiological agent that contributed to this global health crisis is by no means the sever...
-
Chapter
Drug Resistance to Antiestrogens
Tamoxifen (Nolvadex®) (Fig. 1), a nonsteroidal antiestrogen, is the endocrine treatment of choice for all stages of breast cancer. The drug has ten million women years of clinical experience and is described b...
-
Chapter and Conference Paper
Taxol plus recombinant human granulocyte colony stimulating factor as salvage chemotherapy for metastatic breast cancer
Clinical trial results in refractory ovarian carcinoma, and more recently in other human malignancies, have led taxol to be referred to as the most promising new chemotherapeutic agent of the decade. Distinct ...